Tysabri

12 results

Perrigo chief executive Murray Kessler said the €297 million tax settlement in the best interest of all of Perrigo’s stakeholders,  removing a major uncertainty for the business.

The chief executive of the Irish-headquartered drug company that agreed a settlement of a record tax bill with the Revenue Commissioners on Wednesday (...)

The Revenue Commissioners have settled a €976 million dispute tax  bill with US pharma company Perrigo for just under €300 million. Photograph: Nick Bradshaw

Over the counter drugs company Perrigo has settled the largest tax bill ever issued by the Revenue Commissioners for €297 million. When credit for cer(...)

Murray Kessler: When I leave a company that is stronger, that people have a good future in, then I’ll have done my job and I can go back to retirement.

Murray Kessler was retired when the call came from Perrigo. After a career in the tobacco and food sectors in the United States, he had turned his att(...)

The Revenue Commissioners now accept that the amount in dispute between it and healthcare group, Perrigo, is less than €1 billion. Photograph: Nick Bradshaw

One of the largest outstanding tax disputes in the State has moved closer to settlement, with the money at issue falling dramatically. Following discu(...)

Ireland’s tax authorities have rejected an offer from consumer healthcare group Perrigo to settle an outstanding €1.64 billion tax bill.  Photograph: Adam Bird/Bloomberg via Getty Images

The State’s tax authorities have rejected an offer from consumer healthcare group Perrigo to settle an outstanding €1.64 billion tax bill. The decis(...)

Perrigo has made an offer to settle a disputed €1.64 billion tax bill levied by Revenue. Photograph: Adam Bird/Bloomberg via Getty

Perrigo has made an offer to settle a disputed €1.64 billion tax bill levied by Revenue related to its purchase in 2013 of Elan Pharmaceuticals. Murr(...)

Any ruling that might affect intellectual property and how it is treated is a matter of significant concern for industry. File photograph: Getty

Ireland’s American business community was strangely quiet yesterday. And it was not entirely because they were keeping close tabs on the see-saw count(...)

Perrigo claims it had a legitimate expectation that the sale of rights to multiple sclerosis drug Tysabri to Biogen would be treated as trading income not a capital gain

Drug company Perrigo is not a “sacrificial victim” of the Revenue Commissioners arising from a €1.6 billion tax assessment, and it has not been single(...)

Revenue says Perrigo owes the €1.64 billion because of its purchase of Irish pharma group Elan in 2013 and the sale by Elan eight months previously of its MS drug Tysabri to Biogen. Photograph: Adam Bird/Bloomberg via Getty Images

The Revenue Commissioners go to court this week to defend on of the most contentious tax bills levied on a company in Ireland. US drug company Perri(...)

Perrigo bought Elan eight months after the company had sold the Tysabri intellectual property.

Over-the-counter drug specialist Perrigo has once again hit out at the Revenue decision to pursue it for €1.64 billion in back taxes. Speaking to ana(...)

  • 1
  • 2
  • Next
  • Last »